Recombinant Dopamine Receptor D2 (DRD2) Homo sapiens (Human) Recombinant protein

DR-D2; D2DR; D2R

  • UOM
    1. 10µg
    2. 50µg
    3. 200µg
    4. 1mg
    5. 5mg
  • FOB US$ 192.00 US$ 480.00 US$ 960.00 US$ 2,880.00 US$ 7,200.00
  • Quantity
    Out of stock
Add to Cart Distributors Free trial
Overview
Properties
  • Source Prokaryotic expression, Host E.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationMembrane
  • Molecular Mass 51.2kDa, Accurate 51kDa(Analysis of differences refer to the manual)
  • Residues & TagsVal200~Ile384 with N-terminal His and GST Tag
  • Buffer Formulation20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder, Purity > 95%
  • Isoelectric Point11.0
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Recombinant Dopamine Receptor D2 (DRD2) Packages (Simulation)
  • Recombinant Dopamine Receptor D2 (DRD2) Packages (Simulation)
  • Recombinant Dopamine Receptor D2 (DRD2) Gene sequencing
  • RPA673Hu01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Sequence

Usage

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • Distinct patterns of outcome valuation and amygdala-prefrontal cortex synaptic remodeling in adolescence and adulthoodPubMed: 25999830
  • Sex differences, learning flexibility, and striatal dopamine D1 and D2 following adolescent drug exposure in ratsPubmed:27091300

Recommend products